APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indapamide

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Indapamide Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchIndapamide Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Indapamide Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Indapamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indapamide Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Indapamide Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Indapamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Indapamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Indapamide include ANI Pharma, Apeloa Kangyu, Cigna, Glenmark Pharmaceuticals, Servier, Supra Chemicals, Taj Pharmaceuticals, Mylan and Shandong Yinfeida Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Indapamide market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Indapamide market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Indapamide market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Indapamide.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Indapamide market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Indapamide Market by Company

ANI Pharma

Apeloa Kangyu

Cigna

Glenmark Pharmaceuticals

Servier

Supra Chemicals

Taj Pharmaceuticals

Mylan

Shandong Yinfeida Pharmaceutical

Suzhou Lixinpharm

Teva

Lisheng Pharma

Indapamide Segment by Type

1.25 mg Indapamide Tablets

2.5 mg Indapamide Tablets

Indapamide Segment by Application

Diuretic

Hypertension Treatment

Other

Indapamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indapamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indapamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indapamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Indapamide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Indapamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1.25 mg Indapamide Tablets Table 2. Major Company of 2.5 mg Indapamide Tablets Table 3. Global Indapamide Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Indapamide Sales by Type (2021-2026) & (K Tons) Table 5. Global Indapamide Sales Market Share in Volume by Type (2021-2026) Table 6. Global Indapamide Sales by Type (2021-2026) & (US$ Million) Table 7. Global Indapamide Sales Market Share in Value by Type (2021-2026) Table 8. Global Indapamide Price by Type (2021-2026) & (US$/Ton) Table 9. Global Indapamide Sales by Type (2027-2032) & (K Tons) Table 10. Global Indapamide Sales Market Share in Volume by Type (2027-2032) Table 11. Global Indapamide Sales by Type (2027-2032) & (US$ Million) Table 12. Global Indapamide Sales Market Share in Value by Type (2027-2032) Table 13. Global Indapamide Price by Type (2027-2032) & (US$/Ton) Table 14. North America Indapamide Sales by Type (2021-2026) & (K Tons) Table 15. North America Indapamide Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Indapamide Sales by Type (2021-2026) & (K Tons) Table 17. Europe Indapamide Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Indapamide Sales by Type (2021-2026) & (K Tons) Table 19. Asia-Pacific Indapamide Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Indapamide Sales by Type (2021-2026) & (K Tons) Table 21. Latin America Indapamide Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Indapamide Sales by Type (2021-2026) & (K Tons) Table 23. Middle East and Africa Indapamide Sales by Type (2021-2026) & (US$ Million) Table 24. Indapamide Industry Trends Table 25. Indapamide Industry Drivers Table 26. Indapamide Industry Opportunities and Challenges Table 27. Indapamide Industry Restraints Table 28. Global Indapamide Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Indapamide Revenue Market Share by Company (2021-2026) Table 30. Global Indapamide Sales by Company (2021-2026) & (K Tons) Table 31. Global Indapamide Sales Share by Company (2021-2026) Table 32. Global Indapamide Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Indapamide Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Indapamide Major Company Production Sites and Headquarters Table 35. Global Indapamide Company, Product Type & Application Table 36. Global Indapamide Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Indapamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Indapamide Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Indapamide Sales by Region (2021-2026) & (K Tons) Table 41. Global Indapamide Sales Market Share in Volume by Region (2021-2026) Table 42. Global Indapamide Sales by Region (2021-2026) & (US$ Million) Table 43. Global Indapamide Sales Market Share in Value by Region (2021-2026) Table 44. Global Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Indapamide Sales by Region (2027-2032) & (K Tons) Table 46. Global Indapamide Sales Market Share in Volume by Region (2027-2032) Table 47. Global Indapamide Sales by Region (2027-2032) & (US$ Million) Table 48. Global Indapamide Sales Market Share in Value by Region (2027-2032) Table 49. Global Indapamide Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Indapamide Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Indapamide Sales by Application (2021-2026) & (K Tons) Table 52. Global Indapamide Sales Market Share in Volume by Application (2021-2026) Table 53. Global Indapamide Sales by Application (2021-2026) & (US$ Million) Table 54. Global Indapamide Sales Market Share in Value by Application (2021-2026) Table 55. Global Indapamide Price by Application (2021-2026) & (US$/Ton) Table 56. Global Indapamide Sales by Application (2027-2032) & (K Tons) Table 57. Global Indapamide Sales Market Share in Volume by Application (2027-2032) Table 58. Global Indapamide Sales by Application (2027-2032) & (US$ Million) Table 59. Global Indapamide Sales Market Share in Value by Application (2027-2032) Table 60. Global Indapamide Price by Application (2027-2032) & (US$/Ton) Table 61. North America Indapamide Sales by Application (2021-2026) & (K Tons) Table 62. North America Indapamide Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Indapamide Sales by Application (2021-2026) & (K Tons) Table 64. Europe Indapamide Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Indapamide Sales by Application (2021-2026) & (K Tons) Table 66. Asia-Pacific Indapamide Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Indapamide Sales by Application (2021-2026) & (K Tons) Table 68. Latin America Indapamide Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Indapamide Sales by Application (2021-2026) & (K Tons) Table 70. Middle East and Africa Indapamide Sales by Application (2021-2026) & (US$ Million) Table 71. ANI Pharma Company Information Table 72. ANI Pharma Business Overview Table 73. ANI Pharma Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. ANI Pharma Indapamide Product Portfolio Table 75. ANI Pharma Recent Development Table 76. Apeloa Kangyu Company Information Table 77. Apeloa Kangyu Business Overview Table 78. Apeloa Kangyu Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Apeloa Kangyu Indapamide Product Portfolio Table 80. Apeloa Kangyu Recent Development Table 81. Cigna Company Information Table 82. Cigna Business Overview Table 83. Cigna Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Cigna Indapamide Product Portfolio Table 85. Cigna Recent Development Table 86. Glenmark Pharmaceuticals Company Information Table 87. Glenmark Pharmaceuticals Business Overview Table 88. Glenmark Pharmaceuticals Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Glenmark Pharmaceuticals Indapamide Product Portfolio Table 90. Glenmark Pharmaceuticals Recent Development Table 91. Servier Company Information Table 92. Servier Business Overview Table 93. Servier Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Servier Indapamide Product Portfolio Table 95. Servier Recent Development Table 96. Supra Chemicals Company Information Table 97. Supra Chemicals Business Overview Table 98. Supra Chemicals Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Supra Chemicals Indapamide Product Portfolio Table 100. Supra Chemicals Recent Development Table 101. Taj Pharmaceuticals Company Information Table 102. Taj Pharmaceuticals Business Overview Table 103. Taj Pharmaceuticals Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Taj Pharmaceuticals Indapamide Product Portfolio Table 105. Taj Pharmaceuticals Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Mylan Indapamide Product Portfolio Table 110. Mylan Recent Development Table 111. Shandong Yinfeida Pharmaceutical Company Information Table 112. Shandong Yinfeida Pharmaceutical Business Overview Table 113. Shandong Yinfeida Pharmaceutical Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio Table 115. Shandong Yinfeida Pharmaceutical Recent Development Table 116. Suzhou Lixinpharm Company Information Table 117. Suzhou Lixinpharm Business Overview Table 118. Suzhou Lixinpharm Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Suzhou Lixinpharm Indapamide Product Portfolio Table 120. Suzhou Lixinpharm Recent Development Table 121. Teva Company Information Table 122. Teva Business Overview Table 123. Teva Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Teva Indapamide Product Portfolio Table 125. Teva Recent Development Table 126. Lisheng Pharma Company Information Table 127. Lisheng Pharma Business Overview Table 128. Lisheng Pharma Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Lisheng Pharma Indapamide Product Portfolio Table 130. Lisheng Pharma Recent Development Table 131. North America Indapamide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 132. North America Indapamide Sales by Country (2021-2026) & (K Tons) Table 133. North America Indapamide Sales Market Share by Country (2021-2026) Table 134. North America Indapamide Sales Forecast by Country (2027-2032) & (K Tons) Table 135. North America Indapamide Sales Market Share Forecast by Country (2027-2032) Table 136. North America Indapamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Indapamide Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Indapamide Market Share by Country (2021-2026) Table 139. North America Indapamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Indapamide Market Share Forecast by Country (2027-2032) Table 141. Europe Indapamide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 142. Europe Indapamide Sales by Country (2021-2026) & (K Tons) Table 143. Europe Indapamide Sales Market Share by Country (2021-2026) Table 144. Europe Indapamide Sales Forecast by Country (2027-2032) & (K Tons) Table 145. Europe Indapamide Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Indapamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Indapamide Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Indapamide Market Share by Country (2021-2026) Table 149. Europe Indapamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Indapamide Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Indapamide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Indapamide Sales by Country (2021-2026) & (K Tons) Table 153. Asia-Pacific Indapamide Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Indapamide Sales Forecast by Country (2027-2032) & (K Tons) Table 155. Asia-Pacific Indapamide Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Indapamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Indapamide Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Indapamide Market Share by Country (2021-2026) Table 159. Asia-Pacific Indapamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Indapamide Market Share Forecast by Country (2027-2032) Table 161. Latin America Indapamide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 162. Latin America Indapamide Sales by Country (2021-2026) & (K Tons) Table 163. Latin America Indapamide Sales Market Share by Country (2021-2026) Table 164. Latin America Indapamide Sales Forecast by Country (2027-2032) & (K Tons) Table 165. Latin America Indapamide Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Indapamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Indapamide Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Indapamide Market Share by Country (2021-2026) Table 169. Latin America Indapamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Indapamide Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Indapamide Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Indapamide Sales by Country (2021-2026) & (K Tons) Table 173. Middle East and Africa Indapamide Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Indapamide Sales Forecast by Country (2027-2032) & (K Tons) Table 175. Middle East and Africa Indapamide Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Indapamide Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Indapamide Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Indapamide Market Share by Country (2021-2026) Table 179. Middle East and Africa Indapamide Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Indapamide Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Indapamide Distributors List Table 184. Indapamide Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Indapamide Image Figure 2. Global Indapamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indapamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Indapamide Sales (2021-2032) & (K Tons) Figure 5. 1.25 mg Indapamide Tablets Image Figure 6. Global 1.25 mg Indapamide Tablets Sales YoY Growth (2021-2032) & (K Tons) Figure 7. 2.5 mg Indapamide Tablets Image Figure 8. Global 2.5 mg Indapamide Tablets Sales YoY Growth (2021-2032) & (K Tons) Figure 9. Global Indapamide Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Indapamide Market Share by Type 2025 VS 2032 Figure 11. North America Indapamide Sales Market Share in Volume by Type in 2025 Figure 12. North America Indapamide Sales Market Share in Value by Type in 2025 Figure 13. Europe Indapamide Sales Market Share in Volume by Type in 2025 Figure 14. Europe Indapamide Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Indapamide Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Indapamide Sales Market Share in Value by Type in 2025 Figure 17. Latin America Indapamide Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Indapamide Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Indapamide Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Indapamide Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Indapamide Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Diuretic Image Figure 24. Global Diuretic Sales YoY Growth (2021-2032) & (K Tons) Figure 25. Hypertension Treatment Image Figure 26. Global Hypertension Treatment Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Global Indapamide Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Indapamide Market Share by Application 2025 VS 2032 Figure 31. North America Indapamide Sales Market Share in Volume by Application in 2025 Figure 32. North America Indapamide Sales Market Share in Value by Application in 2025 Figure 33. Europe Indapamide Sales Market Share in Volume by Application in 2025 Figure 34. Europe Indapamide Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Indapamide Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Indapamide Sales Market Share in Value by Application in 2025 Figure 37. Latin America Indapamide Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Indapamide Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Indapamide Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Indapamide Sales Market Share in Value by Application in 2025 Figure 41. North America Indapamide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 42. North America Indapamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Indapamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Indapamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Indapamide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 46. Europe Indapamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Indapamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Indapamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Indapamide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 50. Asia-Pacific Indapamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Indapamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Indapamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Indapamide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 54. Latin America Indapamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Indapamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Indapamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Indapamide Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 58. Middle East and Africa Indapamide Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Indapamide Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Indapamide Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Indapamide Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Indapamide Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 1.25 mg Indapamide Tablets
  • 2.5 mg Indapamide Tablets
Applications
  • Diuretic
  • Hypertension Treatment
  • Other
Companies covered
  • ANI Pharma
  • Apeloa Kangyu
  • Cigna
  • Glenmark Pharmaceuticals
  • Servier
  • Supra Chemicals
  • Taj Pharmaceuticals
  • Mylan
  • Shandong Yinfeida Pharmaceutical
  • Suzhou Lixinpharm
  • Teva
  • Lisheng Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Indapamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Indapamide Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Indapamide Market by Type
  6. 1.3.1 1.25 mg Indapamide Tablets
  7. 1.3.2 2.5 mg Indapamide Tablets
  8. 1.4 Global Indapamide Market Size by Type
  9. 1.4.1 Global Indapamide Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Indapamide Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Indapamide Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Indapamide Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Indapamide Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Indapamide Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Indapamide Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Indapamide Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Indapamide Industry Trends
  2. 2.2 Indapamide Industry Drivers
  3. 2.3 Indapamide Industry Opportunities and Challenges
  4. 2.4 Indapamide Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Indapamide Revenue (2021-2026)
  2. 3.2 Global Top Players by Indapamide Sales (2021-2026)
  3. 3.3 Global Top Players by Indapamide Price (2021-2026)
  4. 3.4 Global Indapamide Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Indapamide Major Company Production Sites & Headquarters
  6. 3.6 Global Indapamide Company, Product Type & Application
  7. 3.7 Global Indapamide Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Indapamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Indapamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Indapamide Tier 1, Tier 2, and Tier 3
4 Indapamide Regional Status and Outlook
  1. 4.1 Global Indapamide Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Indapamide Historic Market Size by Region
  3. 4.2.1 Global Indapamide Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Indapamide Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Indapamide Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Indapamide Forecasted Market Size by Region
  7. 4.3.1 Global Indapamide Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Indapamide Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Indapamide Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Indapamide by Application
  1. 5.1 Indapamide Market by Application
  2. 5.1.1 Diuretic
  3. 5.1.2 Hypertension Treatment
  4. 5.1.3 Other
  5. 5.2 Global Indapamide Market Size by Application
  6. 5.2.1 Global Indapamide Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Indapamide Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Indapamide Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Indapamide Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Indapamide Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Indapamide Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Indapamide Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Indapamide Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ANI Pharma
  2. 6.1.1 ANI Pharma Company Information
  3. 6.1.2 ANI Pharma Business Overview
  4. 6.1.3 ANI Pharma Indapamide Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ANI Pharma Indapamide Product Portfolio
  6. 6.1.5 ANI Pharma Recent Developments
  7. 6.2 Apeloa Kangyu
  8. 6.2.1 Apeloa Kangyu Company Information
  9. 6.2.2 Apeloa Kangyu Business Overview
  10. 6.2.3 Apeloa Kangyu Indapamide Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Apeloa Kangyu Indapamide Product Portfolio
  12. 6.2.5 Apeloa Kangyu Recent Developments
  13. 6.3 Cigna
  14. 6.3.1 Cigna Company Information
  15. 6.3.2 Cigna Business Overview
  16. 6.3.3 Cigna Indapamide Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cigna Indapamide Product Portfolio
  18. 6.3.5 Cigna Recent Developments
  19. 6.4 Glenmark Pharmaceuticals
  20. 6.4.1 Glenmark Pharmaceuticals Company Information
  21. 6.4.2 Glenmark Pharmaceuticals Business Overview
  22. 6.4.3 Glenmark Pharmaceuticals Indapamide Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glenmark Pharmaceuticals Indapamide Product Portfolio
  24. 6.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 6.5 Servier
  26. 6.5.1 Servier Company Information
  27. 6.5.2 Servier Business Overview
  28. 6.5.3 Servier Indapamide Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Servier Indapamide Product Portfolio
  30. 6.5.5 Servier Recent Developments
  31. 6.6 Supra Chemicals
  32. 6.6.1 Supra Chemicals Company Information
  33. 6.6.2 Supra Chemicals Business Overview
  34. 6.6.3 Supra Chemicals Indapamide Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Supra Chemicals Indapamide Product Portfolio
  36. 6.6.5 Supra Chemicals Recent Developments
  37. 6.7 Taj Pharmaceuticals
  38. 6.7.1 Taj Pharmaceuticals Company Information
  39. 6.7.2 Taj Pharmaceuticals Business Overview
  40. 6.7.3 Taj Pharmaceuticals Indapamide Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Taj Pharmaceuticals Indapamide Product Portfolio
  42. 6.7.5 Taj Pharmaceuticals Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Indapamide Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Indapamide Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Shandong Yinfeida Pharmaceutical
  50. 6.9.1 Shandong Yinfeida Pharmaceutical Company Information
  51. 6.9.2 Shandong Yinfeida Pharmaceutical Business Overview
  52. 6.9.3 Shandong Yinfeida Pharmaceutical Indapamide Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio
  54. 6.9.5 Shandong Yinfeida Pharmaceutical Recent Developments
  55. 6.10 Suzhou Lixinpharm
  56. 6.10.1 Suzhou Lixinpharm Company Information
  57. 6.10.2 Suzhou Lixinpharm Business Overview
  58. 6.10.3 Suzhou Lixinpharm Indapamide Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Suzhou Lixinpharm Indapamide Product Portfolio
  60. 6.10.5 Suzhou Lixinpharm Recent Developments
  61. 6.11 Teva
  62. 6.11.1 Teva Company Information
  63. 6.11.2 Teva Business Overview
  64. 6.11.3 Teva Indapamide Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Teva Indapamide Product Portfolio
  66. 6.11.5 Teva Recent Developments
  67. 6.12 Lisheng Pharma
  68. 6.12.1 Lisheng Pharma Company Information
  69. 6.12.2 Lisheng Pharma Business Overview
  70. 6.12.3 Lisheng Pharma Indapamide Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lisheng Pharma Indapamide Product Portfolio
  72. 6.12.5 Lisheng Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Indapamide Sales by Country
  2. 7.1.1 North America Indapamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Indapamide Sales by Country (2021-2026)
  4. 7.1.3 North America Indapamide Sales Forecast by Country (2027-2032)
  5. 7.2 North America Indapamide Market Size by Country
  6. 7.2.1 North America Indapamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Indapamide Market Size by Country (2021-2026)
  8. 7.2.3 North America Indapamide Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Indapamide Sales by Country
  2. 8.1.1 Europe Indapamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Indapamide Sales by Country (2021-2026)
  4. 8.1.3 Europe Indapamide Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Indapamide Market Size by Country
  6. 8.2.1 Europe Indapamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Indapamide Market Size by Country (2021-2026)
  8. 8.2.3 Europe Indapamide Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Indapamide Sales by Country
  2. 9.1.1 Asia-Pacific Indapamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Indapamide Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Indapamide Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Indapamide Market Size by Country
  6. 9.2.1 Asia-Pacific Indapamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Indapamide Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Indapamide Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Indapamide Sales by Country
  2. 10.1.1 South America Indapamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Indapamide Sales by Country (2021-2026)
  4. 10.1.3 South America Indapamide Sales Forecast by Country (2027-2032)
  5. 10.2 South America Indapamide Market Size by Country
  6. 10.2.1 South America Indapamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Indapamide Market Size by Country (2021-2026)
  8. 10.2.3 South America Indapamide Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Indapamide Sales by Country
  2. 11.1.1 Middle East and Africa Indapamide Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Indapamide Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Indapamide Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Indapamide Market Size by Country
  6. 11.2.1 Middle East and Africa Indapamide Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Indapamide Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Indapamide Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Indapamide Value Chain Analysis
  2. 12.1.1 Indapamide Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Indapamide Production Mode & Process
  7. 12.2 Indapamide Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Indapamide Distributors
  10. 12.2.3 Indapamide Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst